{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morristown",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65702",
      "recalling_firm": "Bayer HealthCare Pharmaceuticals Inc.",
      "address_1": "36 Columbia Rd",
      "address_2": "N/A",
      "postal_code": "07960-4526",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "NY, CA",
      "recall_number": "D-807-2013",
      "product_description": "Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin",
      "product_quantity": "194.62 kg",
      "reason_for_recall": "Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.",
      "recall_initiation_date": "20130613",
      "center_classification_date": "20130718",
      "termination_date": "20140210",
      "report_date": "20130724",
      "code_info": "Lot 87100040"
    }
  ]
}